(Q33537849)

27 July 2017

1 reference

title

Complement-mediated acute effects of liposome-encapsulated hemoglobin (English)

1 reference

27 July 2017

Szebeni J

1

1 reference

27 July 2017

Alving CR

series ordinal

2

1 reference

27 July 2017

publication date

1 January 1999

1 reference

Artificial Cells, Blood Substitutes, and Biotechnology

27 July 2017

published in

1 reference

27 July 2017

volume

27

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

23-41

1 reference

Current status of injectable oxygen carriers

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10731199909117481

The effects of recombinant human hemoglobin on esophageal motor functions in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199909117481

In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199909117481

Role of complement in rats injected with liposome-encapsulated hemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199909117481

Structure and function of the anaphylatoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199909117481

Effects of the anaphylatoxins on circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199909117481

C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199909117481

Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199909117481

Allergic reactions and other rare side-effects of liposomal amphotericin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199909117481

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199909117481

Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199909117481

Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199909117481

Thromboxane receptor blockade improves oxygenation in an experimental model of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199909117481

10.3109/10731199909117481

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference